Clinical Trials · NCT00966355
Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Korea University
- Enrollment
- 1,034
- Start date
- Sep 2006
- Locations
- 1 site, South Korea
- Primary endpoint
- 5-day Treatment Failure (Failure to Control Bleeding, Rebleeding, or Death)